GlobeNewswire Inc.··Nxera PharmaEli Lilly Acquires Centessa Pharmaceuticals in Sleep-Wake Drug Push
Eli Lilly acquires Centessa Pharmaceuticals, developer of OX2R agonists for sleep disorders co-created with Nxera Pharma, which retains milestone payments and royalties.
LLYCNTAacquisitiondrug discovery